World Health Organization, August 1, 2018 The WHO PrEP Implementation Tool App for Health Workers App is now available. On-the-go access to the following modules from the WHO PrEP Implementation Tool: Clinical: for clinicians, including physicians, nurses and clinical officers Counsellors: for staff who counsel people as they consider or start taking PrEP, and support them in coping with side...
Priorities for preventing a concentrated HIV epidemic among Aboriginal and Torres Strait Islander Australians James S Ward, Karen Hawke and Rebecca J Guy Med J Aust 2018; 209 (1): 56. || doi: 10.5694/mja17.01071 Published online: 2 July 2018 Greater efforts are required to prevent human immunodeficiency virus infection (HIV) escalating among Aboriginal and Torres Strait Islander Australians...
Lancet HIV (2018). Published online 06 June 2018. doi: 10.1016/S2352-301830072-9. Abstract: Background Pre-exposure prophylaxis (PrEP) has been rapidly rolled out in large, publicly funded implementation projects in Victoria and New South Wales, Australia. Using behavioural surveillance of gay and bisexual men, we analysed the uptake and effect of PrEP, particularly on condom use by gay and...
Science Daily, December 19, 2017 A new study suggests that the most beneficial age for a one-time screening HIV test of the general population would be age 25. The report — led by researchers at Massachusetts General Hospital working with the U.S. Centers for Disease Control and Prevention (CDC) and the Massachusetts Department of Public Health — will be published in the Journal of...
Specialty Pharmacy Times, Tuesday, October 17, 2017 Patients with HIV who smoke may have an increased risk of lung cancer mortality compared with the risk of dying from HIV, according to a new study published by JAMA Internal Medicine. These findings suggest that healthcare providers should strongly advocate for smoking cessation and cancer screening for patients with HIV. The abstract...
Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...